GO:1990788 GLI-SUFU complex: Components, Assembly and Research Methods

The GLI-SUFU complex (GO:1990788) is a protein complex that represses GLI's transcription factor activity when SMO signaling is inactive. In mammals, it consists of SUFU and one of the GLI family proteins. This complex is a critical node in the Hedgehog signaling pathway, which controls embryonic development and tissue homeostasis. Upon ligand binding to the upstream receptor PTC (Patched), GLI dissociates from SUFU and activates transcription of hedgehog-target genes. Dysregulation of this complex is implicated in cancers such as medulloblastoma and in developmental disorders like Gorlin syndrome. Researchers study GO:1990788 to understand how Hedgehog signals are transduced and to identify therapeutic targets. Recent structural predictions using AlphaFold3 have revealed novel GLI-SUFU interfaces and binding-defective SUFU missense variants from patients, highlighting the complex's clinical relevance. Additionally, morphogen-induced kinase condensates can allosterically activate GLI, providing new insights into signal transduction. The kinesin-4 protein Kif7 regulates mammalian Hedgehog signalling by organizing the cilium tip compartment, further linking the GLI-SUFU complex to cellular architecture. Sonic hedgehog acts as a chemotactic neural crest cell guide, and its perturbation by ethanol exposure affects neural crest development, underscoring the complex's role in development.

The GLI-SUFU complex is a protein repressing GLI's transcription factor activity when SMO signaling is inactive. Upon ligand binding to the upstream receptor PTC (Patched), GLI dissociates from SUFU and activates transcription of hedgehog-target genes. In mammals it consists of SUFU and one of the GLI family proteins.

The GLI-SUFU complex is essential for proper Hedgehog signaling, which regulates cell fate, proliferation, and differentiation during development and tissue repair. Its dysfunction leads to uncontrolled Hedgehog pathway activation, a hallmark of several cancers including medulloblastoma and basal cell carcinoma, as well as developmental disorders such as Gorlin syndrome. Understanding the structural interfaces and regulatory mechanisms of this complex can inform targeted therapies. Recent studies have identified binding-defective SUFU missense variants in patients, directly linking complex integrity to disease. Moreover, the complex is dynamically regulated by kinase condensates and ciliary proteins like Kif7, offering multiple points for therapeutic intervention.

The following genes and proteins are key components or regulators of the GLI-SUFU complex and its signaling pathway.

The GLI-SUFU complex is regulated by multiple mechanisms. In the absence of Hedgehog ligand, PTC inhibits SMO, allowing SUFU to bind GLI and repress its activity. Upon ligand binding to PTC, SMO is activated and promotes GLI dissociation from SUFU, enabling GLI to activate target genes. Kinase condensates induced by morphogens can allosterically activate GLI, providing an additional layer of regulation. Kif7 organizes the cilium tip compartment and influences the localization and stability of the complex. Phosphorylation of GLI by kinases such as PKA, CK1, and GSK3B modulates its interaction with SUFU and its processing. These regulatory inputs ensure precise control of Hedgehog signaling output.

Medulloblastoma is a common pediatric brain cancer often driven by aberrant Hedgehog signaling. Mutations in SUFU that disrupt GLI-SUFU complex formation lead to constitutive GLI activation and tumorigenesis. AlphaFold3 predictions have identified binding-defective SUFU missense variants in medulloblastoma patients, highlighting the complex as a diagnostic and therapeutic target.

Gorlin syndrome is an inherited disorder characterized by basal cell carcinomas, jaw cysts, and skeletal abnormalities. It is caused by mutations in PTCH1 or SUFU, both of which affect the GLI-SUFU complex. SUFU variants that impair GLI binding result in unchecked Hedgehog signaling and disease manifestations.

Sonic hedgehog acts as a chemotactic neural crest cell guide, and its perturbation by ethanol exposure disrupts neural crest migration. Since GLI-SUFU complex mediates Hedgehog signaling, ethanol-induced changes in this pathway may contribute to fetal alcohol spectrum disorders. This links the complex to developmental teratogenesis.

Kif7 regulates mammalian Hedgehog signalling by organizing the cilium tip compartment, and mutations in Kif7 cause ciliopathies with Hedgehog-related phenotypes. Disruption of ciliary transport affects GLI-SUFU complex localization and function, contributing to diseases such as Joubert syndrome.

AlphaFold3 predictions can identify novel GLI-SUFU interfaces and binding-defective variants. These predictions are validated by co-immunoprecipitation, crosslinking mass spectrometry, and site-directed mutagenesis. Such methods reveal how patient-derived missense variants disrupt complex formation.

Affinity purification coupled with mass spectrometry (AP-MS) can identify components of the GLI-SUFU complex and its dynamic interactors. Proximity labeling (BioID) in live cells can capture transient interactions at the primary cilium. These approaches help map the complex's composition under different signaling states.

Fluorescence microscopy with tagged GLI and SUFU can visualize complex localization at the cilium tip. Kif7 organizes this compartment, and live-cell imaging can track complex dynamics upon ligand stimulation. Super-resolution microscopy can resolve subciliary domains.

RNA-seq and luciferase reporter assays measure GLI target gene activation following complex dissociation. Quantitative PCR for targets like GLI1 and PTCH1 provides a readout of Hedgehog pathway activity. These methods are used to assess the functional impact of mutations in SUFU or GLI.

Researchers studying GLI-SUFU complex-related genes often need to determine whether a candidate gene is causally involved in Hedgehog signaling, cancer, or developmental disorders. EDITGENE provides a comprehensive suite of CRISPR-based services to create precise cell models for such investigations.

The GLI-SUFU complex (GO:1990788) is a central repressor of Hedgehog signaling, with critical roles in development and disease. Its composition, regulation, and structural interfaces are active areas of research, informed by AlphaFold3 predictions and functional studies. Understanding this complex offers opportunities for therapeutic intervention in cancers and developmental disorders. EDITGENE provides comprehensive CRISPR services to facilitate such research.